Cargando…

Mass Spectrometric Analysis of Intact Human Monoclonal Antibody Aggregates Fractionated by Size-Exclusion Chromatography

PURPOSE: The aim of this study was to develop a method to characterize intact soluble monoclonal IgG1 antibody (IgG) oligomers by mass spectrometry. METHODS: IgG aggregates (dimers, trimers, tetramers and high-molecular-weight oligomers) were created by subjecting an IgG formulation to several pH ju...

Descripción completa

Detalles Bibliográficos
Autores principales: Kükrer, Başak, Filipe, Vasco, van Duijn, Esther, Kasper, Piotr T., Vreeken, Rob J., Heck, Albert J. R., Jiskoot, Wim
Formato: Texto
Lenguaje:English
Publicado: Springer US 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939344/
https://www.ncbi.nlm.nih.gov/pubmed/20680668
http://dx.doi.org/10.1007/s11095-010-0224-5
_version_ 1782186709284290560
author Kükrer, Başak
Filipe, Vasco
van Duijn, Esther
Kasper, Piotr T.
Vreeken, Rob J.
Heck, Albert J. R.
Jiskoot, Wim
author_facet Kükrer, Başak
Filipe, Vasco
van Duijn, Esther
Kasper, Piotr T.
Vreeken, Rob J.
Heck, Albert J. R.
Jiskoot, Wim
author_sort Kükrer, Başak
collection PubMed
description PURPOSE: The aim of this study was to develop a method to characterize intact soluble monoclonal IgG1 antibody (IgG) oligomers by mass spectrometry. METHODS: IgG aggregates (dimers, trimers, tetramers and high-molecular-weight oligomers) were created by subjecting an IgG formulation to several pH jumps. Protein oligomer fractions were isolated by high performance size exclusion chromatography (HP-SEC), dialyzed against ammonium acetate pH 6.0 (a mass spectrometry-compatible volatile buffer), and analyzed by native electrospray ionization time-of-flight mass spectrometry (ESI-TOF MS). RESULTS: Monomeric and aggregated IgG fractions in the stressed IgG formulation were successfully isolated by HP-SEC. ESI-TOF MS analysis enabled us to determine the molecular weight of the monomeric IgG as well as the aggregates, including dimers, trimers and tetramers. HP-SEC separation and sample preparation proved to be necessary for good quality signal in ESI-TOF MS. Both the HP-SEC protocol and the ESI-TOF mass spectrometric technique were shown to leave the IgG oligomers largely intact. CONCLUSIONS: ESI-TOF MS is a useful tool complementary to HP-SEC to identify and characterize small oligomeric protein aggregates.
format Text
id pubmed-2939344
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-29393442010-10-05 Mass Spectrometric Analysis of Intact Human Monoclonal Antibody Aggregates Fractionated by Size-Exclusion Chromatography Kükrer, Başak Filipe, Vasco van Duijn, Esther Kasper, Piotr T. Vreeken, Rob J. Heck, Albert J. R. Jiskoot, Wim Pharm Res Research Paper PURPOSE: The aim of this study was to develop a method to characterize intact soluble monoclonal IgG1 antibody (IgG) oligomers by mass spectrometry. METHODS: IgG aggregates (dimers, trimers, tetramers and high-molecular-weight oligomers) were created by subjecting an IgG formulation to several pH jumps. Protein oligomer fractions were isolated by high performance size exclusion chromatography (HP-SEC), dialyzed against ammonium acetate pH 6.0 (a mass spectrometry-compatible volatile buffer), and analyzed by native electrospray ionization time-of-flight mass spectrometry (ESI-TOF MS). RESULTS: Monomeric and aggregated IgG fractions in the stressed IgG formulation were successfully isolated by HP-SEC. ESI-TOF MS analysis enabled us to determine the molecular weight of the monomeric IgG as well as the aggregates, including dimers, trimers and tetramers. HP-SEC separation and sample preparation proved to be necessary for good quality signal in ESI-TOF MS. Both the HP-SEC protocol and the ESI-TOF mass spectrometric technique were shown to leave the IgG oligomers largely intact. CONCLUSIONS: ESI-TOF MS is a useful tool complementary to HP-SEC to identify and characterize small oligomeric protein aggregates. Springer US 2010-08-03 2010 /pmc/articles/PMC2939344/ /pubmed/20680668 http://dx.doi.org/10.1007/s11095-010-0224-5 Text en © The Author(s) 2010 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Research Paper
Kükrer, Başak
Filipe, Vasco
van Duijn, Esther
Kasper, Piotr T.
Vreeken, Rob J.
Heck, Albert J. R.
Jiskoot, Wim
Mass Spectrometric Analysis of Intact Human Monoclonal Antibody Aggregates Fractionated by Size-Exclusion Chromatography
title Mass Spectrometric Analysis of Intact Human Monoclonal Antibody Aggregates Fractionated by Size-Exclusion Chromatography
title_full Mass Spectrometric Analysis of Intact Human Monoclonal Antibody Aggregates Fractionated by Size-Exclusion Chromatography
title_fullStr Mass Spectrometric Analysis of Intact Human Monoclonal Antibody Aggregates Fractionated by Size-Exclusion Chromatography
title_full_unstemmed Mass Spectrometric Analysis of Intact Human Monoclonal Antibody Aggregates Fractionated by Size-Exclusion Chromatography
title_short Mass Spectrometric Analysis of Intact Human Monoclonal Antibody Aggregates Fractionated by Size-Exclusion Chromatography
title_sort mass spectrometric analysis of intact human monoclonal antibody aggregates fractionated by size-exclusion chromatography
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939344/
https://www.ncbi.nlm.nih.gov/pubmed/20680668
http://dx.doi.org/10.1007/s11095-010-0224-5
work_keys_str_mv AT kukrerbasak massspectrometricanalysisofintacthumanmonoclonalantibodyaggregatesfractionatedbysizeexclusionchromatography
AT filipevasco massspectrometricanalysisofintacthumanmonoclonalantibodyaggregatesfractionatedbysizeexclusionchromatography
AT vanduijnesther massspectrometricanalysisofintacthumanmonoclonalantibodyaggregatesfractionatedbysizeexclusionchromatography
AT kasperpiotrt massspectrometricanalysisofintacthumanmonoclonalantibodyaggregatesfractionatedbysizeexclusionchromatography
AT vreekenrobj massspectrometricanalysisofintacthumanmonoclonalantibodyaggregatesfractionatedbysizeexclusionchromatography
AT heckalbertjr massspectrometricanalysisofintacthumanmonoclonalantibodyaggregatesfractionatedbysizeexclusionchromatography
AT jiskootwim massspectrometricanalysisofintacthumanmonoclonalantibodyaggregatesfractionatedbysizeexclusionchromatography